Archives of Medical Research
Volume 35, Issue 6 , Pages 495-498 , November 2004

The hypotensive effect of BMY 7378 involves central 5-HT1A receptor stimulation in the adult but not in the young rat

  • Rafael Villalobos-Molina

      Affiliations

    • Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados- IPN, Sede Sur, México City, México
    • Corresponding Author InformationAddress reprint requests to: Rafael Villalobos-Molina, Ph.D., Departamento de Farmacobiología, CINVESTAV-Sede Sur, Calz. Tenorios 235, Col. Granjas Coapa, México, D.F. 14330, México. Tel. (52 55)5061-2857; Fax. (52 55)5061-2863
    • ,
  • Miguel Gil-Flores

      Affiliations

    • Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados- IPN, Sede Sur, México City, México
    • ,
  • Itzell A. Gallardo-Ortiz

      Affiliations

    • Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados- IPN, Sede Sur, México City, México
    • ,
  • J. Javier López-Guerrero

      Affiliations

    • Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados- IPN, Sede Sur, México City, México
    • ,
  • Maximiliano Ibarra

      Affiliations

    • Unidad de Biomedicina, Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, México City, Mexico

Received 2 April 2004 ,Accepted 16 July 2004.

References 

  1. Kuhn DM, Wolf WA, Lovenberg W. Review of the role of the central serotoninergic neuronal system in blood pressure regulation. Hypertension. 1980;2:243–255
  2. Gradin K, Pettersson A, Hedner T, Persson B. Acute administration of 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat. J Neural Transmission. 1985;62:302–319
  3. Martin GE, Lis EV. Hypotensive action of 8-hydroxy-2-(di-N-propylamino) tetralin (8-OH-DPAT) in spontaneously hypertensive rats. Arch Int Pharmacodyn. 1985;273:251–261
  4. Dabire H, Cherqui C, Fournier B, Schmitt H. Comparison of effects of some 5-HT1 agonists on blood pressure and heart rate of normotensive anaesthetized rats. Eur J Pharmacol. 1987;140:259–266
  5. Fozard JR, Mir AK, Middlemiss DN. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol. 1987;9:328–347
  6. Deng XF, Chemtob S, Varma DR. Characterization of α1-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br J Pharmacol. 1996;119:269–276
  7. Villalobos-Molina R, Lopez-Guerrero JJ, Ibarra M. The hypotensive effect of BMY 7378 is antagonized by a silent 5-HT1A receptor antagonist: comparison with 8-hydroxy-dipropylamino tetralin. Arch Med Res. 2001;32:389–393
  8. Fletcher A, Bill SJ, Forster EA, Jones D, Reilly J. A pharmacological profile of WAY-100635, a potent and selective 5-HT1A receptor antagonist. Br J Pharmacol. 1994;112:91P(Suppl)
  9. Goetz AS, King HK, Ward SDC, True TA, Rimele TJ, Saussy DL. BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors. Eur J Pharmacol. 1995;272:R5–R6
  10. Testa R, Guarneri L, Poggesi E, Angelico P, Velasco C, Ibba M, et al. Effect of several 5-hydroxytryptamine1A receptor ligands on the micturition reflex in rats: comparison with WAY 100635. JPET. 1999;290:1258–1269
  11. Villalobos-Molina R, López-Guerrero JJ, Gallardo-Ortíz IA, Ibarra M. Evidence that the hypotensive effect of WAY 100635, a 5-HT1A receptor antagonist, is related to vascular α1-adrenoceptor blockade in the adult rat. Auton Autacoid Pharmacol. 2002;22:171–176
  12. Folkow B, Svanborg A. Physiology of cardiovascular aging. Physiol Rev. 1993;73:725–764
  13. Ibarra M, Terron JA, Lopez-Guerrero JJ, Villalobos-Molina R. Evidence for an age-dependent functional expression of α1D-adrenoceptors in the vasculature of the pithed rat. Eur J Pharmacol. 1997;322:285–287
  14. Villalobos-Molina R, López-Guerrero JJ, Ibarra M. Functional evidence of α1D-adrenoceptors in the vasculature of young and adult spontaneously hypertensive rats. Br J Pharmacol. 1999;126:1534–1536
  15. Nénonéné EK, Radja F, Carli M, Grondin L, Reader TA. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxy dipropyl aminotetralin. J Neurochem. 1994;62:1822–1834
  16. Stubbs CM, Connor HE, Feniuk W. BMY 7378 is an agonist at 5-HT1A receptor mediating hypotension and renal sympatho-inhibition in anaesthetised cats. Eur J Pharmacol. 1991;197:113–116
  17. Maines LW, Keck BJ, Dugar A, Lakoski JM. Age-dependent loss of corticosterone modulation of central serotonin 5-HT1A receptor binding sites. J Neurosci Res. 1998;53:86–98
  18. Nyakas C, Oosterink BJ, Keijser J, Felszhegy K, de Jong GI, Korf J, et al. Selective decline of 5-HT1A receptor binding sites in rat cortex, hippocampus and cholinergic basal forebrain during aging. J Chem Neuroanat. 1997;13:53–61
  19. Zifa E, Hernandez J, Fayolle C, Fillion G. Postnatal development of 5-HT1 receptors: [3H]5-HT binding sites and 5-HT induced adenylate cyclase activations in rat brain cortex. Brain Res Dev Brain Res. 1988;44:196–206
  20. Terrón JA. Role of 5-HT7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat. Br J Pharmacol. 1997;121:563–571
  21. Kogan HA, Marsden CA, Fone KCF. DR4004, a putative 5-HT7 receptor antagonist, also has functional activity at dopamine D2 receptor. Eur J Pharmacol. 2002;449:105–111
  22. Borella A, Bindra M, Whitaker-Azmitia PM. Role of the 5-HT1A in development of the neonatal rat brain: preliminary behavioral studies. Neuropharmacology. 1997;36:445–450

PII: S0188-4409(04)00140-7

doi: 10.1016/j.arcmed.2004.11.009

Archives of Medical Research
Volume 35, Issue 6 , Pages 495-498 , November 2004

Article Tools

* Image Usage & Resolution